5PSQ-067 Analysis of antineoplastic drugs preparation errors as a first step to improve the quality of the process

BACKGROUND: Antineoplastic preparation presents unique safety concerns because of its toxicity and narrow therapeutic window. Moreover, the antineoplastic use system includes several stages that are vulnerable to opportunities for potentially harmful medication errors. PURPOSE: To identify the type...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Hosp Pharm
Päätekijät: Alfaro, B Marzal, Escudero-Vilaplana, V, Rodríguez-González, CG, Peña, E González-Haba, García-González, X, Ibañez-García, S, García-Moreno, FJ, Ortega-Navarro, C, Iglesias-Peinado, I, Herranz, A, Sanjurjo-Saez, M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2018
Aiheet:
Section 5: Patient safety and quality assurance
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535736/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.421
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia